[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345256-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345256-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cdkn2ap16-exon-2-hypermethylation-in-lung-squamous-cell-carcinoma-associated-with-interstitial-and-emphysematous-lung-diseases-a-comparative-analysis-of-tumor-adjacent-and-distant-lung-tissues","CDKN2A/p16 Exon 2 Hypermethylation in Lung Squamous Cell Carcinoma Associated with Interstitial and Emphysematous Lung Diseases - A Comparative Analysis of Tumor, Adjacent and Distant Lung Tissues","","Lung squamous cell carcinoma (LUSC) often develops in interstitial or emphysematous lung diseases, including idiopathic pulmonary fibrosis (IPF), pulmonary emphysema (PE), and smoking-related interstitial fibrosis (SRIF), where field cancerization may extend. Promoter regions of p16, CDH13, and RASSF1A, and p16 exon 2, were evaluated by methylation-specific PCR in tumor, adjacent (\u003C3 cm), and distant (≥3 cm) tissues from 25 LUSC patients. p16 exon 2 methylation was higher in tumors than in non-tumorous tissue in PE and SRIF cases, while IPF showed hypermethylation in distant tissues. p16 promoter hypermethylation was frequent in stage II or higher; p16 expression was lower in IPF and PE than SRIF, with no consistent CDH13 or RASSF1A patterns, suggesting disease- and stage-related heterogeneity and an epigenetic field effect.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cdkn2ap16-exon-2-hypermethylation-in-lung-squamous-cell-carcinoma-associated-with-interstitial-and-emphysematous-lung-diseases-a-comparative-analysis-of-tumor-adjacent-and-distant-lung-tissues/345256/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cdkn2ap16-exon-2-hypermethylation-in-lung-squamous-cell-carcinoma-associated-with-interstitial-and-emphysematous-lung-diseases-a-comparative-analysis-of-tumor-adjacent-and-distant-lung-tissues/345256.png","ImageObject",300,407,{"name":42,"@type":43},"Noah","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What molecular change was most consistently observed across lung tissues in this study?","Question",{"text":63,"@type":64},"p16 exon 2 methylation was frequently detected, with tumor tissues showing higher methylation overall, and distant tissues in IPF cases also showing hypermethylation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did p16 exon 2 methylation differ among IPF, PE, and SRIF-associated LUSC?",{"text":68,"@type":64},"In PE and SRIF cases, p16 exon 2 methylation was significantly higher in tumors than in non-tumorous tissues, whereas IPF cases showed p16 exon 2 hypermethylation extending to distant tissues.",{"name":70,"@type":61,"acceptedAnswer":71},"Were promoter methylation and protein expression patterns uniform across all genes studied?",{"text":72,"@type":64},"p16 promoter hypermethylation was frequently seen in stage II or higher, and p16 protein expression was generally reduced in IPF and PE compared with SRIF. In contrast, CDH13 and RASSF1A showed no consistent methylation or expression patterns.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345256,1790194229,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Article  \nCDKN2A/p16 Exon 2 Hypermethylation in Lung Squamous Cell Carcinoma Associated with Interstitial and Emphysematous Lung Diseases: A Comparative Analysis of Tumor, Adjacent and Distant Lung Tissues  \nKeita Miyakawa 1,2, Kyohei Oyama 3, Jiayao Liu 1, Naoko Akiyama 1, Akira Sakata 1, Manami Hayashi 1, Yuki Kamikokura 1, Naoko Aoki 1, Sayaka Yuzawa 1, Shin Ichihara 1, Takaaki Sasaki 4, Masahiro Kitada 5, Yusuke Mizukami 6,7 and Mishie Tanino 1, *  \nReceived: 3 February 2026  \nRevised: 16 March 2026  \nAccepted: 25 March 2026  \nPublished: 27 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Diagnostic Pathology, Asahikawa Medical University Hospital, Asahikawa 078-8510, Japan; [miyakawa@hirosaki-u.ac.jp](miyakawa@hirosaki-u.ac.jp) (K.M.)  \n2 Department of Bioscience and Laboratory Medicine, Hirosaki University Graduate School of Health Sciences, Hirosaki 036-8564, Japan  \n3 Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa 078-8510, Japan  \n4 Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa 078-8510, Japan  \n5 Department of Thoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Asahikawa 078-8510, Japan  \n6 Division of Gastroenterology, Department of Medicine, Asahikawa Medical University, Asahikawa 078-8510, Japan  \n7 Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan  \n* [Correspondence: mtanino@asahikawa-med.ac.jp](Correspondence: mtanino@asahikawa-med.ac.jp); Tel.: +81-166-69-3393  \nSimple Summary  \nLung squamous cell carcinoma (LUSC) frequently develops in patients with chronic lung diseases, including idiopathic pulmonary fibrosis (IPF), pulmonary emphysema, and smoking-related interstitial fibrosis (SRIF); however, the underlying carcinogenetic mechanisms remain unclear. We investigated selected molecular alterations in tumor and non-tumorous lung tissues from patients with LUSC arising in these underlying diseases. Methylation-specific PCR revealed frequent p16 exon 2 methylation in tumor tissues across all cases. Notably, p16 exon 2 methylation was also detected in distant non-tumor lung tissue from patients with IPF, a pattern not observed for the promoter of p16, CDH13, or RASSF1A. Furthermore, p16 protein expression was lower in IPF-or PE-associated LUSC than in SRIF-associated LUSC. These results suggest that the carcinogenetic processes underlying LUSC may vary according to the type of pre-existing lung disease. Elucidating these disease-specific molecular pathways may contribute to improved detection and therapeutic strategies for LUSC in patients with chronic lung disorders.  \nAbstract  \nLung squamous cell carcinoma (LUSC) tends to arise in the setting of interstitial or emphysematous lung diseases, including idiopathic pulmonary fibrosis (IPF), pulmonary emphysema (PE), and smoking-related interstitial fibrosis (SRIF), where field cancerization may extend. DNA methylation of promoter regions of p16, CDH13, and RASSF1A and p16 exon 2 was assessed by methylation-specific PCR. Tumor, adjacent (\u003C3 cm), and distant (≥3 cm) lung tissues were obtained from 25 patients with LUSC (IPF, n = 7; PE, n = 8; SRIF, n = 10). p16 exon 2 methylation was significantly higher in tumors than in non-tumorous tissues in PE and SRIF cases. In contrast, IPF cases showed p16 exon 2 hypermethylation also  \nin distant tissues. Across tumor samples, p16 promoter hypermethylation was frequently observed in stage II or higher. p16 expression in tumors was generally reduced in IPF and PE cases, compared with SRIF cases. No consistent methylation or expression patterns were observed for CDH13 or RASSF1A. p16-associated molecular alterations exhibited diseas","cbCaish2XSkk8OI5","https://ap.wps.com/l/cbCaish2XSkk8OI5","pdf",3659943,16,"English","# Introduction\n## Lung field cancerization and lung cancer risk\n## Disease-associated carcinogenesis in LUSC","[{\"question\":\"What molecular change was most consistently observed across lung tissues in this study?\",\"answer\":\"p16 exon 2 methylation was frequently detected, with tumor tissues showing higher methylation overall, and distant tissues in IPF cases also showing hypermethylation.\"},{\"question\":\"How did p16 exon 2 methylation differ among IPF, PE, and SRIF-associated LUSC?\",\"answer\":\"In PE and SRIF cases, p16 exon 2 methylation was significantly higher in tumors than in non-tumorous tissues, whereas IPF cases showed p16 exon 2 hypermethylation extending to distant tissues.\"},{\"question\":\"Were promoter methylation and protein expression patterns uniform across all genes studied?\",\"answer\":\"p16 promoter hypermethylation was frequently seen in stage II or higher, and p16 protein expression was generally reduced in IPF and PE compared with SRIF. In contrast, CDH13 and RASSF1A showed no consistent methylation or expression patterns.\"}]","CDKN2A/p16 Exon 2 Hypermethylation in Lung Squamous Cell Carcinoma Associated with Interstitial and Emphysematous Lung Diseases - A Comparative Analysis of Tumor, Adjacent and Distant Lung Tissues | PDF",1790056969,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59afaa100a886a2cf20b3477cb7c828f.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e74da035d14fb5343b2e1d488a54072e.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3de1a3c0644a77606c8ccd15fa3b420d.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/085f71cea9bb6997bd3cf8c117b4420d.webp",980,1385]